COPD-Management nach aktuellen Leitlinien bei niedergelassenen Pneumologen

Hintergrund und Fragestellung: Methode: Ergebnisse: Schlussfolgerung: Background: Methods: Results: Conclusion:

[1]  C. Jenkins,et al.  The TORCH (TOwards a Revolution in COPD Health) survival study protocol , 2004, European Respiratory Journal.

[2]  J. Vestbo,et al.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.

[3]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.

[4]  E. Wouters,et al.  Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. , 2001, The European respiratory journal.

[5]  S. Ramsey,et al.  Suboptimal medical therapy in COPD: exploring the causes and consequences. , 2000, Chest.

[6]  Terry S. Field,et al.  Knowledge, patterns of care, and outcomes of care for generalists and specialists , 1999, Journal of General Internal Medicine.

[7]  J. Grimshaw,et al.  Potential benefits, limitations, and harms of clinical guidelines , 1999, BMJ.

[8]  H. Folgering,et al.  Pulmonary rehabilitation in chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[9]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[10]  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.

[11]  M. Decramer,et al.  COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2004 .